Cleared Traditional

K904541 - LABELING SUBMITTAL, ADX TM CANNABINOIDS-GS (FDA 510(k) Clearance)

Nov 1990
Decision
47d
Days
Class 2
Risk

K904541 is an FDA 510(k) clearance for the LABELING SUBMITTAL, ADX TM CANNABINOIDS-GS. This device is classified as a Enzyme Immunoassay, Cannabinoids (Class II - Special Controls, product code LDJ).

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on November 20, 1990, 47 days after receiving the submission on October 4, 1990.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3870.

Submission Details

510(k) Number K904541 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 1990
Decision Date November 20, 1990
Days to Decision 47 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code LDJ — Enzyme Immunoassay, Cannabinoids
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3870

Similar Devices — LDJ Enzyme Immunoassay, Cannabinoids

Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test COT
K223162 · Healgen Scientific, LLC · Mar 2023
Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine Calibrators, Immunalysis cTHC Urine Control Set
K151203 · Immunalysis Corporation · Jun 2015
LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls
K141320 · Lin-Zhi International, Inc. · May 2015